Jason W. Myers's Insider Trades & SAST Disclosures
Jason W. Myers's most recent trade in Invitae Corp was a trade of 310,597 Common Stock done . Disclosure was reported to the exchange on Feb. 19, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jason W. Myers.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Invitae Corp | Jason W. Myers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Feb 2021 | 310,597 | 100,000 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 51.54 per share. | 23 Dec 2020 | 66,421 | 518,328 (0%) | 0% | 51.5 | 3,423,564 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 52.62 per share. | 23 Dec 2020 | 53,653 | 464,675 (0%) | 0% | 52.6 | 2,823,355 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 47.03 per share. | 23 Dec 2020 | 24,161 | 435,407 (0%) | 0% | 47.0 | 1,136,270 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 49.04 per share. | 23 Dec 2020 | 14,800 | 414,749 (0%) | 0% | 49.0 | 725,730 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 47.85 per share. | 23 Dec 2020 | 5,858 | 429,549 (0%) | 0% | 47.8 | 280,300 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 53.38 per share. | 23 Dec 2020 | 5,007 | 459,668 (0%) | 0% | 53.4 | 267,293 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 49.77 per share. | 23 Dec 2020 | 3,752 | 410,997 (0%) | 0% | 49.8 | 186,732 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 50.58 per share. | 23 Dec 2020 | 400 | 410,597 (0%) | 0% | 50.6 | 20,230 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 54.04 per share. | 23 Dec 2020 | 100 | 459,568 (0%) | 0% | 54.0 | 5,404 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 49.95 per share. | 21 Dec 2020 | 73,310 | 709,940 (0%) | 0% | 49.9 | 3,661,827 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 52.84 per share. | 21 Dec 2020 | 70,942 | 634,098 (0%) | 0% | 52.8 | 3,748,696 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 53.43 per share. | 21 Dec 2020 | 42,338 | 591,760 (0%) | 0% | 53.4 | 2,262,306 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 49.24 per share. | 21 Dec 2020 | 19,297 | 783,250 (0%) | 0% | 49.2 | 950,238 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 54.27 per share. | 21 Dec 2020 | 7,011 | 584,749 (0%) | 0% | 54.3 | 380,491 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 51.73 per share. | 21 Dec 2020 | 4,700 | 705,040 (0%) | 0% | 51.7 | 243,114 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 47.81 per share. | 21 Dec 2020 | 3,935 | 802,547 (0%) | 0% | 47.8 | 188,141 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 47.10 per share. | 21 Dec 2020 | 3,232 | 806,482 (0%) | 0% | 47.1 | 152,218 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 50.54 per share. | 21 Dec 2020 | 200 | 709,740 (0%) | 0% | 50.5 | 10,109 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Dec 2020 | 300,000 | 941,065 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2020 | 171,872 | 1,211,099 (1%) | 0% | - | Common Stock | |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2020 | 152,527 | 1,363,626 (1%) | 0% | - | Common Stock | |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 47.39 per share. | 14 Dec 2020 | 81,677 | 859,388 (0%) | 0% | 47.4 | 3,870,371 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 47.32 per share. | 14 Dec 2020 | 71,869 | 1,291,757 (1%) | 0% | 47.3 | 3,400,877 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 48.18 per share. | 14 Dec 2020 | 49,474 | 809,914 (0%) | 0% | 48.2 | 2,383,697 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 47.27 per share. | 14 Dec 2020 | 33,340 | 1,246,335 (1%) | 0% | 47.3 | 1,576,075 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 46.64 per share. | 14 Dec 2020 | 12,082 | 1,279,675 (1%) | 0% | 46.6 | 563,474 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 48.23 per share. | 14 Dec 2020 | 5,270 | 1,241,065 (1%) | 0% | 48.2 | 254,187 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 48.78 per share. | 14 Dec 2020 | 200 | 809,714 (0%) | 0% | 48.8 | 9,755 | Common Stock |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2020 | 1,039,227 | 1,039,227 (1%) | 1% | - | Common Stock | |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2020 | 643,839 | 643,839 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Jason W. Myers | Director, President, Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2020 | 278,417 | 278,417 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges